EUVIMEDEUVIMED entdecken
Crossref

Global Burden of Major Chronic Liver Diseases in 2021

Gong Feng, Yusuf Yilmaz iD, Luca Valenti iD, Wai-Kay Seto iD, Calvin Q Pan iD, Nahum Méndez-Sánchez iD, Feng Ye, Silvia Sookoian iD, Giovanni Targher iD, Christopher D Byrne, Wah-Kheong Chan iD, Sombat Treeprasertsuk und 29 weitere

Liver International · 2025-04 · 45 (4)

DOI: 10.1111/liv.70058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 10.03.2025. Verfasst von Gong Feng und 40 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Liver Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study utilised the Global Burden of Disease data (2010–2021) to analyse the rates and trends in point prevalence, annual incidence and years lived with disability (YLDs) for major chronic liver diseases, such as hepatitis B, hepatitis C, metabolic dysfunction‐associated liver disease, cirrhosis and other chronic liver diseases.

Methods

Age‐standardised rates per 100,000 population for prevalence, annual incidence and YLDs were compared across regions and countries, as well as the socio‐demographic index (SDI). Trends were expressed as percentage changes (PC) and estimates were reported with uncertainty intervals (UI).

Results

Globally, in 2021, the age‐standardised rates per 100,000 population for the prevalence of hepatitis B, hepatitis C, MASLD and cirrhosis and other chronic liver diseases were 3583.6 (95%UI 3293.6–3887.7), 1717.8 (1385.5–2075.3), 15018.1 (13756.5–16361.4) and 20302.6 (18845.2–21791.9) respectively. From 2010 to 2021, the PC in age‐standardised prevalence rates were−20.4% for hepatitis B, −5.1% for hepatitis C, +11.2% for MASLD and + 2.6% for cirrhosis and other chronic liver diseases. Over the same period, the PC in age‐standardized incidence rates were ‐24.7%, ‐6.8%, +3.2%, and +3.0%, respectively. Generally, negative associations, but with fluctuations, were found between age‐standardised prevalence rates for hepatitis B, hepatitis C, cirrhosis and other chronic liver diseases and the SDI at a global level. However, MASLD prevalence peaked at moderate SDI levels.

Conclusions

The global burden of chronic liver diseases remains substantial. Hepatitis B and C have decreased in prevalence and incidence in the last decade, while MASLD, cirrhosis and other chronic liver diseases have increased, necessitating targeted public health strategies and resource allocation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Global Burden of DiseaseLiver DiseasesHumansPrevalenceIncidenceMaleMiddle AgedFemaleAdultGlobal HealthLiver CirrhosisChronic DiseaseAgedYoung AdultHepatitis C, ChronicHepatitis B, ChronicDisability-Adjusted Life YearsAdolescent

Stichwörter der Autor:innen

chronic liver diseasesglobal burden of diseasesincidenceprevalence

Autor:innen und Institutionen

  • Xi'an Medical University, Xi'an, China.
  • The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Precision Medicine and Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano, Milan, Italy.
  • Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Yusuf Yilmaz, Luca Valenti, Wai-Kay Seto, Calvin Q Pan, Nahum Méndez-Sánchez, Silvia Sookoian, Giovanni Targher, Wah-Kheong Chan, Seung Up Kim, Giada Sebastiani, Monica Lupșor-Platon, Saeed Hamid, Vasily Isakov, Qiuwei Pan, Shiv Kumar Sarin, Jörn M Schattenberg, Mohammadjavad Sotoudeheian, Jin Chai, Yasser Fouad, Vincent Wai-Sun Wong, Ming-Hua Zheng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, G., Yilmaz, Y., Valenti, L., Seto, W. K., Pan, C. Q., Méndez-Sánchez, N., Ye, F., Sookoian, S., Targher, G., Byrne, C. D., Chan, W. K., Treeprasertsuk, S., Yu, H. H., Kim, S. U., George, J., Xu, W. J., Sebastiani, G., Ocama, P., Ryan, J. D., …, & Zheng, M. H. (2025). Global Burden of Major Chronic Liver Diseases in 2021. Liver International, 45(4). https://doi.org/10.1111/liv.70058

Vancouver

Feng G, Yilmaz Y, Valenti L, Seto WK, Pan CQ, Méndez-Sánchez N, et al. Global Burden of Major Chronic Liver Diseases in 2021. Liver International. 2025;45(4). doi:10.1111/liv.70058

BibTeX
@article{Feng2025,
  author = {Feng, Gong and Yilmaz, Yusuf and Valenti, Luca and Seto, Wai-Kay and Pan, Calvin Q and Méndez-Sánchez, Nahum and Ye, Feng and Sookoian, Silvia and Targher, Giovanni and Byrne, Christopher D and Chan, Wah-Kheong and Treeprasertsuk, Sombat and Yu, Hon Ho and Kim, Seung Up and George, Jacob and Xu, Wen-Jing and Sebastiani, Giada and Ocama, Ponsiano and Ryan, John D and Lupșor-Platon, Monica and Ghazinyan, Hasmik and Hamid, Saeed and Perera, Nilanka and Alswat, Khalid and Isakov, Vasily and Pan, Qiuwei and Sarin, Shiv Kumar and Schattenberg, Jörn M and Sotoudeheian, Mohammadjavad and Wong, Yu Jun and Sharara, Ala I and Al-Busafi, Said A and Opio, Christopher Kenneth and Chai, Jin and Fouad, Yasser and Shi, Yu and Al-Mahtab, Mamun and Zhang, Sujuan and Pirola, Carlos Jose and Wong, Vincent Wai-Sun and Zheng, Ming-Hua},
  title = {Global Burden of Major Chronic Liver Diseases in 2021},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {4},
  doi = {10.1111/liv.70058}
}
Kostenlos starten →